BioCatalystWatch
GTBPWorkspace / GTBP / OverviewCompany library
GT Biopharma, Inc. logo

GT Biopharma, Inc.

GT Biopharma, Inc. (GTBP)

Website

Featured programme · cam1615SS1

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Other pipelines

OXS-4235

PreINDP1P2P3FilingApproved
GTB-5550

CD16 × B7-H3 (CD276)

PreINDP1P2P3FilingApproved
GTB-5550

CD16 × B7-H3 (CD276)

PreINDP2P3FilingApproved
GTB-5550

CD16 × B7-H3 (CD276)

PreINDP1P2P3FilingApproved
GTB-7550

CD16 × CD19

PreINDP1P2P3FilingApproved
cam1615SS1

CD16 × Mesothelin

PreINDP1P2P3FilingApproved

History / paused

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

GTBP SEC archive